BRAINSTORM CELL THERAPEUTICS INC. 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Dec 14, 2015
Insider Transaction Report
Form 4
SHORR ROBERT G L
Director
Transactions
- Sale
Common Stock
2015-12-10$2.71/sh−5,500$14,905→ 44,499 total - Sale
Common Stock
2015-12-11$2.56/sh−5,300$13,568→ 39,199 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.66 to $2.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.